ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657270; 2) Community: the network communities that were significantly associated with the response to NSC 657270; 3) Molecule: the relationships between components within communities and NSC 657270; 4) MDR: the compounds that were significantly associated with the NSC 657270.

NSC Compound Enrichment Correlation
NSC 711077 Null 0.0480633950058475 0.12267269
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.20041316
NSC 726578 Null 0.0480633950058475 0.10563195
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0480633950058475 0.095944234
NSC 749600 Null 0.0480633950058475 0.11312239
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0480633950058475 0.16830998
NSC 753661 methyl ester prodigiosene 0.0480633950058475 0.20941305
NSC 758670 TANNIC ACID 0.0480633950058475 -0.0074998636
NSC 93819 Depakine 0.0480633950058475 0.12087767
NSC 368697 Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- 1.18259685778446e-005 0.33670393
Total:116  Current:114    [First] [Prev] [Next] [Last]